IVD Contract Manufacturing Market is predicted to reach USD 40.1 billion at a CAGR of 12.00% during the forecast period 2023-2032.

Market Research Future (MRFR) has published on the “Global IVD Contract Manufacturing Market”. The IVD Contract Manufacturing market is estimated to register a CAGR of 12.00% during the forecast period of 2024 to 2032.

IVD Contract Manufacturing Market Highlights

The global IVD Contract Manufacturing market has registered a CAGR of 12.00% during the forecast period and is estimated to reach USD 40.1 billion by 2032.

The rising prevalence of chronic illnesses and infectious diseases overall is driving the interest in IVD items, including diagnostic kits and reagents. Additionally, setting up contract fabricating offices for IVD items requires a huge starting interest in foundation, device, and skilled personnel, which can be a barrier for new participants. Furthermore, the rising adoption of point-of-care testing gadgets for fast and decentralized diagnostics is driving interest in contract fabricating administrations fit for creating convenient, simple-to-utilize, and dependable demonstrative gadgets. Moreover, safeguarding intellectual property (IP) privileges while working together with IVD organizations presents difficulties for contract makers in protecting exclusive data and forestalling the unapproved use or disclosure of secret information.

Key Players

MRFR recognizes the following companies as the key players in the global IVD Contract Manufacturing market— Jabil Inc., Sanmina Corporation, TE Connectivity, Celestica Inc., Savyon Diagnostics, West Pharmaceutical Services, Inc., Thermofisher, Biofortuna, and Invetech.

Segment Analysis

The global IVD Contract Manufacturing market has been segmented based on device type, technology, and service type.

Based on the device type, the market is segmented into IVD consumables and IVD equipment. The IVD consumables segment was attributed to holding the largest market share in 2023. Several benefits include cost savings, diminished risk, decreased period length to showcase the item after creation, sped-up advancement, and accessibility to innovations. CMOs can provide more prominent adaptability in terms of creation volume, group size, and item blend. This can be useful for organizations that are growing new items or that have fluctuating interest. For instance, a CMO might have the option to create little bunches of another item to test the market, or they might have the option to increment production volume to satisfy the need for a current item.

The global IVD Contract Manufacturing market has been segmented based on technology into immunoassay, clinical chemistry, hematology, microbiology, molecular diagnostics, coagulation & hemostasis, and others. In 2023, the immunoassay segment acquired the biggest share of the market. The adoption of protein-connected immunoassay quick tests has expanded because of their capacity to give testing in remote areas or emergencies where no refined or cutting-edge innovation is accessible for sickness screening. This supports market development.

Based on the service type, the global IVD Contract Manufacturing market has been segmented into assay development services, manufacturing services, and other services. The category for assay development services was predicted to hold the largest market share in 2023. A huge number of contract makers giving assay services to various analyzers and consumables created by the OEMs and the tremendous ascent in new and proficient tests for immunoassays, molecular diagnostic tests, clinical science testing, and so on are factors that impact the growth of the market.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of IVD Contract Manufacturing Market Research Report

Regional Analysis

Based on region, the global IVD Contract Manufacturing market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America consists of the US and Canada. The European IVD Contract Manufacturing market comprises Germany, France, the UK, Italy, Spain, and the rest of Europe. The IVD Contract Manufacturing market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World's IVD Contract Manufacturing market comprises the Middle East, Africa, and Latin America.

The North American regional sector maintained the largest market share. The IVD contract manufacturing market in North America has been consistently developing as individuals become more aware of the advantages of neuromonitoring in surgeries. North America has a perceptible pattern toward decentralized testing, particularly concerning point-of-care diagnostics. The IVD contract manufacturing market in the U.S. has been encountering consistent development because of the rising interest in indicative tests, innovative progressions, and the requirement for practical assembling arrangements. The rising predominance of ongoing sicknesses in the U.S., like diabetes, cardiovascular illnesses, and disease, has added to the interest in symptomatic tests, cultivating development in the IVD contract fabricating area. Government programs and general well-being efforts might influence the interest in specific demonstrative tests. For example, drives focused on sickness avoidance or screening may be the main thrust behind the interest in specific IVD items.

Moreover, the European market has been persistently growing over the forecast period. Europe has a deeply grounded administrative structure for IVD items, incorporating the In Vitro Diagnostic Medical Devices Regulation (IVDR). This regulation guarantees exclusive expectations of value, security, and execution for IVD items, driving the interest for contract manufacturing administrations that consent to regulatory requirements.

Additionally, Asia Pacific is anticipated to experience the quickest growth over the forecast period. Asia-Pacific commands a huge share in the in vitro diagnostics (IVD) contract manufacturing market because of a few variables. The region's flourishing medical services industry, expanding interest in diagnostic solutions, and a quickly developing populace add to showcase strength. In addition, Asia-Pacific offers cost-effective assembling abilities, attracting worldwide IVD organizations looking for proficient creation. The presence of skilled labor, technological advancements, and steady government drives further upgrade the region's prominence quality in the IVD contract-producing area, cementing its situation as a critical center for assembling and development in the demonstrative business.

Furthermore, the rest of the world's IVD Contract Manufacturing market is divided into the Middle East, Africa, and Latin America. This growth is attributed to the region's growing prevalence of infectious diseases, government initiatives, and growing healthcare expenditure, all of which contribute to the market expansion.

Key Findings of the Study

• The global IVD Contract Manufacturing market is expected to reach USD 40.1 billion by 2032, at a CAGR of 12.00% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market. Expanding awareness about preventive medical care, early sickness detection, and customized medication drives interest in analytic tests and contract manufacturing services among medical care suppliers and buyers in the Asia Pacific region.


• Based on Device Type, the IVD Consumables segment was attributed to holding the largest market in 2023.


• Jabil Inc., Sanmina Corporation, TE Connectivity, Celestica Inc., Savyon Diagnostics, West Pharmaceutical Services, Inc., Thermofisher, Biofortuna, and Invetech are the key market players.